Today's Top 5
5. The Evolving Cancer Care Landscape
The evolving #cancer care landscape has many challenges including rising cost of care, increasing volume/age of population, & increasing complexity of therapeutics. @flatironhealth #AMCCBS #ValueBasedCare #PatientExperience https://t.co/3vLOGAlVLB pic.twitter.com/NgS96DnByr
— Kristin Ferguson, DNP, RN, OCN (@KFerg86) March 3, 2021
4. Which Cancers are Caused by HPV?
Which cancers are caused by HPV? HPV infection can cause cervical cancer, anal cancer, oral cancer, oropharyngeal cancer, and other cancers: https://t.co/FUaWjRvXZY pic.twitter.com/qm0Z2sEXpI
— National Cancer Institute (@theNCI) March 4, 2021
3. Phase 1b Data on Ixazomib for ER+ Breast Cancer
Excited to share our results (@DartmouthLab) showing safety/tolerability and preliminary efficacy (Phase Ib) of oral proteasome inhibitor Ixazomib plus Fulvestrant in advanced, fulvestrant-resistant ER+ Breast Cancer in @OncJournal. https://t.co/ZrIGwa6CGJ @DartmouthHitch
— Kevin Shee, MD, PhD (@KShee11) March 3, 2021
2. Webinar: Addressing Cancer Treatment-Related Aging
Register for a @NCIBehaviors - @NCICancerCtrl webinar on March 15 at 12:00pm EDT to hear Dr. Nathan LeBrasseur and Dr. Jessica Scott describe interventions to address cancer and treatment-related aging using a cells-to-society perspective: https://t.co/W2jY1Ts0xj
— Gabor Liposits (@G_LipositsMD) March 5, 2021
1. Early Detection of Relapsed/Refractory Multiple Myeloma
👏👏 a nuanced take on what is relapsed myeloma. Should we treat at clinical progression? Biochemical progression? MRD conversion or persistent MRD positivity? Can be a slippery slope - odds are you can find some disease if you look deep enough! #mmMRD https://t.co/alz4ZOG888
— Ben Derman (@bdermanmd) March 5, 2021